A.G. Unnikrishnan

Dr. A.G. Unnikrishnan is the CEO of Chellaram Diabetes Institute, recognized for his contributions to endocrinology. He emphasizes the broader systemic health benefits of Wegovy, including improvements in insulin function and potential neuroprotective effects.